Latest news
New Review Finds Opioids Often Ineffective for Acute Pain - Pain Medicine NewsPain Medicine News · Mon, 10 Aug 2026 04:19:35 GMTLatigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs - MedCity NewsMedCity News · Sun, 09 Aug 2026 22:02:34 GMTTargeting small group of brain cells may reduce opioid addiction risk - news-medical.netnews-medical.net · Sat, 08 Aug 2026 02:55:00 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTLatigo prices upsized IPO at $345.6M to fund non-opioid pain drugs - DealroomDealroom · Fri, 07 Aug 2026 01:32:17 GMTLatigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 11:55:09 GMTChasing Vertex, Latigo reports non-opioid pain drug succeeds in key trial - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTLatigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx - STATSTAT · Wed, 29 Jul 2026 07:00:00 GMT